An article in Arthritis & Rheumatology describes how the Supreme Court’s June 24th decision to overturn Roe v. Wade portends grave consequences for the practice of rheumatology.
Abortion bans that have been drafted by more than half of US states can now be implemented, and many more are in development. For patients with rheumatic diseases, family planning choices will be limited, thereby restricting their options for medical treatment. Providers will be forced to weigh delivering evidence-based clinical recommendations against the personal, professional, and legal risks of violating constraints on reproductive rights.
The authors stress that pregnancy can be dangerous for some individuals with rheumatic diseases, and many of the medications that benefit patients with conditions such as rheumatoid arthritis and lupus have been linked to birth defects.
“Many patients with rheumatic diseases are reproductive aged women whose complicated diseases are exacerbated by pregnancy, especially when unplanned. This burden of illness is more pronounced in racial and ethnic minority women, who face both greater morbidity and mortality due to their illness and often live in states with the most restrictive abortion legislation,” said lead author Bonnie L. Bermas, MD, of UTSouthwestern Medical Center. “Thus, the recent Supreme Court Dobbs v. Jackson Women’s health organization decision not only negatively impacts our ability to provide the best healthcare for all of our patients, but also furthers the existing structural racism that impedes the delivery of appropriate reproductive and rheumatic disease care for our minoritized patients.”
URL Upon Publication: https://onlinelibrary.wiley.com/doi/10.1002/art.42336
Additional Information
NOTE: The information contained in this release is protected by copyright. Please include journal attribution in all coverage. For more information or to obtain a PDF of any study, please contact:
Sara Henning-Stout, newsroom@wiley.com
About the Journal
Arthritis & Rheumatology , an official journal of the American College of Rheumatology, is a peer-reviewed publication for scientists and clinicians interested in the natural history, pathophysiology, treatment, and outcome of the rheumatic diseases. The journal publishes the highest quality basic and clinical research related to the rheumatic diseases, encompassing a wide range of areas of investigative activity. In addition, Arthritis & Rheumatology publishes review articles, editorials, and other educational material intended for both researchers and clinicians.
About Wiley
Wiley is a global leader in research and education, unlocking human potential by enabling discovery, powering education, and shaping workforces. For over 200 years, Wiley has fueled the world’s knowledge ecosystem. Today, our high-impact content, platforms, and services help researchers, learners, institutions, and corporations achieve their goals in an ever-changing world. Visit us at Wiley.com , like us on Facebook and follow us on Twitter and LinkedIn .
Arthritis & Rheumatology
Overturning Roe v. Wade: Toppling the Practice of Rheumatology
21-Sep-2022